Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories Intl (NY: CRL )

223.42 +3.14 (+1.43%)
Streaming Delayed Price Updated: 1:02 PM EDT, Jul 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories Intl

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Charles River Laboratories to Participate in June Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories to Host Virtual Investor Day
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Acquires Viral Vector Player For $350M
Contract researcher Charles River Laboratories International Inc (NYSE: CRL) will dole out $292.5 million for gene therapy CDMO Vigene Biosciences with the... 
Via Benzinga
Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
From Charles River Laboratories International, Inc.
Via Business Wire
Stocks That Hit 52-Week Highs On Thursday
Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
Charles River Labs Joins Elite List Of Stocks With 95-Plus Composite Rating
Charles River Labs' Accumulation/Distribution Rating of A, on an A+ to E scale, shows heavy buying by institutional investors over the last 13 weeks. 
Via Investor's Business Daily
Charles River Laboratories International Inc (CRL) Q1 2021 Earnings Call Transcript
CRL earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Charles River: Q1 Earnings Insights
Shares of Charles River (NYSE:CRL) decreased 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 37.50% year over... 
Via Benzinga
Charles River Laboratories Announces First-Quarter 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Three Medical Stocks To Watch, Including One With A Potential Breakout
Two have recent breakouts under their belts while a third is eyeing a fresh buy point. 
Via Investor's Business Daily
Medpace Holdings Stock At The Top Of Buy Range With Earnings On Deck
Medpace is in a potential buy range with its next earnings report scheduled for Apr. 26. The medical stock is about 3% above a 177.22 buy point from a second-stage... Read More 
Via Investor's Business Daily
Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.